The new 3X100mm device includes 0.014 guide-wires and its proprietary technology combines the functionality of a balloon angioplasty device with the addition of built-in embolic capture.

Proteus is a percutaneous transluminal angioplasty balloon, which during deflation captures and removes harmful embolic material from the body.

Angioslide CEO Lihu Avitov said introduction of the new BTK, low-profile Proteus platform, supports the company’s commitment to improve procedure outcomes.

"PROTEUS will become a necessary device in the "tool-box" of physicians practicing "endovascular-first" approach," Avitov added.